Cargando…
Safety and Effectiveness of Hydroxychloroquine and Azithromycin Combination Therapy for Treatment of Hospitalized Patients with COVID-19: A Propensity-Matched Study
INTRODUCTION: We sought to determine the effectiveness and safety of hydroxychloroquine–azithromycin (HCQ-AZM) therapy in hospitalized patients with COVID-19. METHODS: This was a retrospective cohort study of 613 patients hospitalized (integrated health system involving three hospitals) for RT-PCR-c...
Autores principales: | Huang, Henry D., Jneid, Hani, Aziz, Mariam, Ravi, Venkatesh, Sharma, Parikshit S., Larsen, Timothy, Chatterjee, Neal, Saour, Basil, Aziz, Zaid, Nayak, Hemal, Trohman, Richard G., Krishnan, Kousik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556606/ https://www.ncbi.nlm.nih.gov/pubmed/33058086 http://dx.doi.org/10.1007/s40119-020-00201-7 |
Ejemplares similares
-
Late-onset interventricular septal perforation from left bundle branch pacing
por: Ravi, Venkatesh, et al.
Publicado: (2020) -
QT interval and arrhythmic safety of hydroxychloroquine monotherapy in coronavirus disease 2019
por: Sridhar, Arun R., et al.
Publicado: (2020) -
Hydroxychloroquine- and azithromycin-related heart disorders
Publicado: (2020) -
Hydroxychloroquine + azithromycin treatment in elderly patients
por: Gautret, Philippe, et al.
Publicado: (2021) -
Hydroxychloroquine or chloroquine +/- azithromycin: heart disorders
Publicado: (2022)